Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression: a review (2026)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB
- Unidade: ICB
- DOI: 10.1016/j.neuint.2025.106091
- Assunto: FISIOLOGIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Neurochemistry International
- ISSN: 1872-9754
- Volume/Número/Paginação/Ano: v. 192, art. 106091, 2026
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GUNDI, Barbara et al. Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression: a review. Neurochemistry International, v. 192, 2026Tradução . . Disponível em: https://doi.org/10.1016/j.neuint.2025.106091. Acesso em: 12 fev. 2026. -
APA
Gundi, B., Ho, H. L., Zhang, X., He, A., Xin, D., Ferreira, A. F. F., et al. (2026). Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression: a review. Neurochemistry International, 192. doi:10.1016/j.neuint.2025.106091 -
NLM
Gundi B, Ho HL, Zhang X, He A, Xin D, Ferreira AFF, Britto LRG de, Feng ZP, Sun HS. Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression: a review [Internet]. Neurochemistry International. 2026 ; 192[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.neuint.2025.106091 -
Vancouver
Gundi B, Ho HL, Zhang X, He A, Xin D, Ferreira AFF, Britto LRG de, Feng ZP, Sun HS. Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression: a review [Internet]. Neurochemistry International. 2026 ; 192[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.neuint.2025.106091 - Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years
- Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- Mitochondrial abnormalities in neurological disorders
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- The role of interleukin-17 in neurological disorders
- Efeitos do exercício físico na função e biogênese mitocondrial em modelo de doença de Parkinson induzido por 6-hidroxidopamina
Informações sobre o DOI: 10.1016/j.neuint.2025.106091 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
